investment

Spanish Pharmaceutical industry bets on research

The Spanish pharmaceutical industry keeps betting on research with an investment of 972 million Euros in 2012. Namely, the investment reached 200 million Euros at the biotechnology sector, 20% of the total budget.

The most important allocation -479 million- was dedicated to clinical trials, most of them in clinical phase III. It must be highlighted that the expense in clinical research has increased 86% in the last nine years. 45% of the budget was dedicated to research contracts with hospitals, universities and public institutions, an activity that increased nearly 5% in 2012.

According to the data of the survey made to members of Farmaindustria, the number of R&D hiring decreased 3,6% in relation to 2011. However, the qualification of the employees is getting higher and higher: four out of five are graduates and doctors. In general figures, Spain is the fourth country in Europe in pharmaceutical workforce with nearly 40,000 jobs.

These data show that, in spite of the present economic situation and the measures of control of expenses, the pharmaceutical industry is still one of the main driving forces of  Spanish R&D. 

Families bet on the Spanish Stock Market

The last report about Property Distribution of quoted Spanish stocks that is made annually by BME reveals that there are more and more families that decide to invest on the Stock Market. Actually, a fourth part of the shares are now in the hands of these investor families, four points more that only a year ago and the highest percentage since nearly a decade.

This rise has been visible since 2008 and has meant a net invest in quoted shares of more than €16,000 million at 2012. Some of the reasons of that trend are the drop of the real-state sector, the downward adjustments of quotations during the crisis or the possibility of choosing the payment in stocks instead of cash.

Bionaturis (ticker BNT) has been quoting at the MAB since January 2012.

Clik here for more information

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR